Genetic instability in the RAD51 and BRCA1 regions in breast cancer
- PMID: 17180310
- PMCID: PMC6275757
- DOI: 10.2478/s11658-006-0063-x
Genetic instability in the RAD51 and BRCA1 regions in breast cancer
Abstract
Breast cancer is the most prevalent cancer type in women. Accumulating evidence indicates that the fidelity of double-strand break repair in response to DNA damage is an important step in mammary neoplasias. The RAD51 and BRCA1 proteins are involved in the repair of double-strand DNA breaks by homologous recombination. In this study, we evaluated loss of heterozygosity (LOH) in the RAD51 and BRCA1 regions, and their association with breast cancer. The polymorphic markers D15S118, D15S214 and D15S1006 were the focus for RAD51, and D17S855 and D17S1323 for BRCA1. Genomic deletion detected by allelic loss varied according to the regions tested, and ranged from 29 to 46% of informative cases for the RAD51 region and from 38 to 42% of informative cases for the BRCA1 region. 25% of breast cancer cases displayed LOH for at least one studied marker in the RAD51 region exclusively. On the other hand, 31% of breast cancer cases manifested LOH for at least one microsatellite marker concomitantly in the RAD51 and BRCA1 regions. LOH in the RAD51 region, similarly as in the BRCA1 region, appeared to correlate with steroid receptor status. The obtained results indicate that alteration in the RAD51 region may contribute to the disturbances of DNA repair involving RAD51 and BRCA1 and thus enhance the risk of breast cancer development.
Similar articles
-
Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.Cancer Detect Prev. 2008;32(2):144-8. doi: 10.1016/j.cdp.2008.06.005. Epub 2008 Jul 16. Cancer Detect Prev. 2008. PMID: 18632222
-
Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer.Med Oncol. 2015 Nov;32(11):246. doi: 10.1007/s12032-015-0691-y. Epub 2015 Oct 3. Med Oncol. 2015. PMID: 26433958 Free PMC article.
-
Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.Pathol Int. 2008 May;58(5):275-81. doi: 10.1111/j.1440-1827.2008.02223.x. Pathol Int. 2008. PMID: 18429825
-
Molecular functions of BRCA1 in the DNA damage response.Cancer Biol Ther. 2004 Jun;3(6):521-7. doi: 10.4161/cbt.3.6.842. Epub 2004 Jun 24. Cancer Biol Ther. 2004. PMID: 15280660 Review.
-
Caretaker Brca1: keeping the genome in the straight and narrow.Breast Cancer Res. 2000;2(2):82-5. doi: 10.1186/bcr37. Epub 2000 Feb 7. Breast Cancer Res. 2000. PMID: 11250695 Free PMC article. Review.
Cited by
-
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review.Cell Mol Biol Lett. 2022 Jan 3;27(1):1. doi: 10.1186/s11658-021-00301-9. Cell Mol Biol Lett. 2022. PMID: 34979906 Free PMC article. Review.
References
-
- Auranen A., Song H., Waterfall C., Dicioccio R.A., Kuschel B., Kjaer S.K., Hogdall E., Hogdall C., Stratton J., Whittemore A.S., Easton D.F., Ponder B.A., Novik K.L., Dunning A.M., Gayther S., Pharoah P.D. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int. J. Cancer. 2005;117:611–618. doi: 10.1002/ijc.21047. - DOI - PubMed
-
- Cousineau I., Abaji C., Belmaaza A. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis. Cancer Res. 2005;65:11384–11391. doi: 10.1158/0008-5472.CAN-05-2156. - DOI - PubMed
-
- Schmutte C., Tombline G., Rhiem K., Sadoff M.M., Schmutzler R., von Deimling A., Fishel R. Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH) Cancer Res. 1999;59:4564–4569. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous